drugset / Trial / NCT01659853

Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

NCT01659853

Phase 3 Completed 70 enrolled Galderma R&D
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and assess the safety of CD07805/47 gel 0.5% applied topically once daily versus azelaic acid gel 15% applied topically twice daily in subjects with moderate to severe facial erythema of rosacea.

Timeline

Start
2012-09
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelaic acid Small molecule 15 % Topical
Subject Brimonidine Small molecule 0.5 % Topical

Indications